The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model

Pramipexole produced long-term improvement of the RLS-like symptoms in our proposed animal model, caused a partial recovery of spinal iron deficiency, and modestly increased D1 receptor affinity.